Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Incretin Effect”

149 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 149 results

Not applicableStudy completedNCT03312179
What this trial is testing

STEMI and Incretins Treatment

Who this might be right for
STEMICoronary Artery DiseaseCoronary Syndrome+2 more
University of Campania Luigi Vanvitelli 900
Not applicableStudy completedNCT06137586
What this trial is testing

The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients with Type 1 Diabetes

Who this might be right for
Type1diabetesHypoglycemiaType 1 Diabetes
University Hospital, Gentofte, Copenhagen 10
Early research (Phase 1)Study completedNCT02673554
What this trial is testing

The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

Who this might be right for
Type 2 Diabetes
Diabeteszentrum Bad Lauterberg im Harz 30
Not applicableStudy completedNCT01607931
What this trial is testing

Exercise, Glucose Kinetics, and the Incretin Effect

Who this might be right for
Type 2 Diabetes
Rigshospitalet, Denmark 12
Not applicableStudy completedNCT01342939
What this trial is testing

Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY)

Who this might be right for
Maturity-onset Diabetes of the Young
University Hospital, Gentofte, Copenhagen 31
Early research (Phase 1)Active Not RecruitingNCT06923839
What this trial is testing

Testing the Potential Metabolic Effect of the Human Gut Bacterial Peptide, RUCILP, in Healthy Men

Who this might be right for
Healthy Male Adults
Oluf Pedersen 15
Not applicableStudy completedNCT01938469
What this trial is testing

Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery

Who this might be right for
Gastric Bypass SurgeryObesity
St. Luke's-Roosevelt Hospital Center 33
Early research (Phase 1)Study completedNCT01079624
What this trial is testing

GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose

Who this might be right for
PhysiologyGastroenterologyEndocrinology
Uppsala University 15
Not applicableStudy completedNCT01607944
What this trial is testing

Incretins and Metabolism

Who this might be right for
Type 2 Diabetes
Rigshospitalet, Denmark 20
Not applicableStudy completedNCT06064084
What this trial is testing

Incretin Effect in Patients With Psoriasis and Controls

Who this might be right for
Psoriasis Vulgaris
University Hospital, Gentofte, Copenhagen 24
Not applicableStudy completedNCT00863564
What this trial is testing

Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese Subjects

Who this might be right for
ObesityPostprandial LipemiaAtherosclerosis+2 more
Aarhus University Hospital 12
Not applicableStudy completedNCT00571220
What this trial is testing

Mechanisms of Diabetes Control After Weight Loss Surgery

Who this might be right for
Gastric Bypass SurgeryObesity
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 20
Not applicableStudy completedNCT00817973
What this trial is testing

Differential Effects of Protein Quality on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes: Comparison of Whey, Casein, Gluten, and Cod Protein

Who this might be right for
Type 2 DiabetesPostprandial Lipemia
Aarhus University Hospital 12
Not applicableStudy completedNCT01281228
What this trial is testing

The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Obesity
Amsterdam UMC, location VUmc 48
Not applicableStudy completedNCT00469833
What this trial is testing

Insulin Secretion in Diabetes Before and After Glycemic Control

Who this might be right for
DiabetesHyperglycemia
US Department of Veterans Affairs 17
Large-scale testing (Phase 3)Study completedNCT04255433
What this trial is testing

Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 13,299
Post-approval studies (Phase 4)UnknownNCT06243536
What this trial is testing

The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients

Who this might be right for
Type 2 DiabetesOverweightDisordered Eating Behaviors
University Hospital Sestre Milosrdnice 60
Post-approval studies (Phase 4)Study completedNCT00951899
What this trial is testing

The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics

Who this might be right for
Type 2 Diabetes
Mayo Clinic 38
Not applicableStudy completedNCT02235584
What this trial is testing

Insulinotropic Effect of GLP-1 and GIP After Dexamethasone

Who this might be right for
Type 2 Diabetes
Hvidovre University Hospital 19
Post-approval studies (Phase 4)Active Not RecruitingNCT06801015
What this trial is testing

Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions

Who this might be right for
Obesity
Mayo Clinic 30
Load More Results